Introduction

This page provides a comprehensive analysis of the known insider trading history of John H Friedman. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate John H Friedman has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CSII / Cardiovascular Systems Inc. Director 0
US:ACOR / Acorda Therapeutics, Inc. Director 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by John H Friedman. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by John H Friedman as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2013-11-12 2013-11-07 4 CSII Cardiovascular Systems Inc
Warrant (Right to Buy)
X - Other -151,617 0 -100.00
2013-11-12 2013-11-07 4 CSII Cardiovascular Systems Inc
Warrant (Right to Buy)
X - Other -151,617 0 -100.00
2013-11-12 2013-11-07 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale -45,065 166,112 -21.34 29.71 -1,338,881 4,935,188
2013-11-12 2013-11-07 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale -45,065 166,112 -21.34 29.71 -1,338,881 4,935,188
2013-11-12 2013-11-07 4 CSII Cardiovascular Systems Inc
Common Stock
X - Other 151,617 211,177 254.56 8.83 1,338,778 1,864,693
2013-11-12 2013-11-07 4 CSII Cardiovascular Systems Inc
Common Stock
X - Other 151,617 211,177 254.56 8.83 1,338,778 1,864,693
2013-09-13 2013-09-10 4 CSII Cardiovascular Systems Inc
Warrant (Right to Buy)
X - Other -107,833 0 -100.00
2013-09-13 2013-09-10 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale -48,273 59,560 -44.77 20.73 -1,000,699 1,234,679
2013-09-13 2013-09-10 4 CSII Cardiovascular Systems Inc
Common Stock
X - Other 107,833 107,833 9.28 1,000,690 1,000,690
2013-09-06 2013-09-04 4 CSII Cardiovascular Systems Inc
Restricted Stock Units
A - Award 4,580 4,580
2012-09-05 2012-08-31 4 CSII Cardiovascular Systems Inc
Restricted Stock Units
A - Award 10,917 10,917
2012-02-17 2012-02-16 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale -5,853 0 -100.00 8.75 -51,218
2012-02-17 2012-02-15 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale -52,972 5,853 -90.05 8.69 -460,343 50,864
2012-02-17 2012-02-14 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale -6,850 58,825 -10.43 8.82 -60,424 518,895
2012-02-01 2012-02-01 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale X -5,796 65,675 -8.11 9.18 -53,189 602,693
2012-02-01 2012-01-31 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale X -18,263 71,471 -20.35 9.20 -168,104 657,862
2012-02-01 2012-01-30 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale X -29,932 89,734 -25.01 9.24 -276,706 829,546
2012-01-27 2012-01-27 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale X -11,738 119,666 -8.93 9.67 -113,456 1,156,656
2012-01-27 2012-01-26 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale X -21,355 131,404 -13.98 9.76 -208,512 1,283,042
2012-01-27 2012-01-25 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale X -28,429 152,759 -15.69 9.68 -275,153 1,478,493
2012-01-24 2012-01-24 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale X -31,240 181,188 -14.71 9.62 -300,429 1,742,449
2012-01-24 2012-01-23 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale X -3,500 212,428 -1.62 10.00 -34,995 2,123,983
2012-01-24 2012-01-20 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale X -9,773 215,928 -4.33 10.00 -97,758 2,159,906
2012-01-20 2012-01-19 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale X -8,300 225,701 -3.55 10.07 -83,606 2,273,486
2012-01-20 2012-01-18 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale X -18,200 234,001 -7.22 9.92 -180,540 2,321,243
2012-01-17 2012-01-17 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale X -5,900 252,201 -2.29 10.20 -60,188 2,572,778
2012-01-17 2012-01-13 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale X -6,000 258,101 -2.27 10.33 -62,002 2,667,138
2012-01-13 2012-01-12 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale X -8,700 264,101 -3.19 10.42 -90,637 2,751,431
2012-01-13 2012-01-11 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale X -8,832 272,801 -3.14 10.44 -92,212 2,848,233
2012-01-09 2012-01-06 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale X -12,557 308,633 -3.91 10.42 -130,854 3,216,203
2012-01-09 2012-01-05 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale X -22,435 321,190 -6.53 10.40 -233,436 3,341,982
2012-01-05 2012-01-04 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale X -20,543 343,625 -5.64 10.25 -210,533 3,521,606
2012-01-05 2012-01-03 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale X -31,855 364,168 -8.04 10.11 -322,089 3,682,139
2011-11-30 2011-11-29 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale -14,700 396,023 -3.58 10.00 -146,947 3,958,804
2011-11-30 2011-11-28 4 CSII Cardiovascular Systems Inc
Common Stock
S - Sale -10,300 410,723 -2.45 10.04 -103,375 4,122,180
2006-02-17 2006-02-15 4 ACOR ACORDA THERAPEUTICS INC
Series K Convertible Preferred Stock
C - Conversion -100,000 0 -100.00
2006-02-17 2006-02-15 4 ACOR ACORDA THERAPEUTICS INC
Series K Convertible Preferred Stock
C - Conversion -100,000 100,000 -50.00
2006-02-17 2006-02-15 4 ACOR ACORDA THERAPEUTICS INC
Series J Convertible Preferred Stock
C - Conversion -935,374 0 -100.00
2006-02-17 2006-02-15 4 ACOR ACORDA THERAPEUTICS INC
Common
C - Conversion 76,923 873,364 9.66
2006-02-17 2006-02-15 4 ACOR ACORDA THERAPEUTICS INC
Common
C - Conversion 76,923 796,441 10.69
2006-02-17 2006-02-15 4 ACOR ACORDA THERAPEUTICS INC
Common
C - Conversion 719,518 719,518
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)